These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 17713823)

  • 1. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
    Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
    Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years.
    Internullo E; Moons J; Nafteux P; Coosemans W; Decker G; De Leyn P; Van Raemdonck D; Lerut T
    Eur J Cardiothorac Surg; 2008 Jun; 33(6):1096-104. PubMed ID: 18407509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of esophagectomy for esophageal cancer in elderly patients: age has little influence on outcome and survival.
    Ruol A; Portale G; Zaninotto G; Cagol M; Cavallin F; Castoro C; Sileni VC; Alfieri R; Rampado S; Ancona E
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1186-92. PubMed ID: 17467427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
    Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
    Makary MA; Kiernan PD; Sheridan MJ; Tonnesen G; Hetrick V; Vaughan B; Graling P; Elster E
    Am Surg; 2003 Aug; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
    Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
    Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction therapy does not increase surgical morbidity after esophagectomy for cancer.
    Lin FC; Durkin AE; Ferguson MK
    Ann Thorac Surg; 2004 Nov; 78(5):1783-9. PubMed ID: 15511475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution.
    Ruol A; Castoro C; Portale G; Cavallin F; Sileni VC; Cagol M; Alfieri R; Corti L; Boso C; Zaninotto G; Peracchia A; Ancona E
    Arch Surg; 2009 Mar; 144(3):247-54; discussion 254. PubMed ID: 19289664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer.
    Meredith KL; Weber JM; Turaga KK; Siegel EM; McLoughlin J; Hoffe S; Marcovalerio M; Shah N; Kelley S; Karl R
    Ann Surg Oncol; 2010 Apr; 17(4):1159-67. PubMed ID: 20140529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity and mortality are not increased after induction chemoradiotherapy followed by esophagectomy in patients with esophageal cancer.
    Berger AC; Scott WJ; Freedman G; Konski A; Weiner L; Cheng JD; Goldberg M
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S16-20. PubMed ID: 16399424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.
    Camerlo A; D'Journo XB; Ouattara M; Trousse D; Doddoli C; Thomas PA
    J Visc Surg; 2012 Jun; 149(3):e203-10. PubMed ID: 22633088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus.
    Donington JS; Miller DL; Allen MS; Deschamps C; Nichols FC; Pairolero PC
    Ann Thorac Surg; 2004 Apr; 77(4):1193-8; discussion 1198-9. PubMed ID: 15063233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy.
    Reynolds JV; Ravi N; Hollywood D; Kennedy MJ; Rowley S; Ryan A; Hughes N; Carey M; Byrne P
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):549-55. PubMed ID: 16935109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
    Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A clinical study of esophagectomy after chemo-radiation therapy for advanced esophageal carcinoma].
    Takeda S; Tokuno K; Nishimura T; Yoshino S; Oka M
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1982-4. PubMed ID: 18219872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response.
    Barbour AP; Jones M; Gonen M; Gotley DC; Thomas J; Thomson DB; Burmeister B; Smithers BM
    Ann Surg Oncol; 2008 Oct; 15(10):2894-902. PubMed ID: 18663531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
    Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
    Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.